Association Between Pulmonary Embolism and COVID-19 in Emergency Department Patients Undergoing Computed Tomography Pulmonary Angiogram: The PEPCOV International Retrospective Study.


Journal

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
ISSN: 1553-2712
Titre abrégé: Acad Emerg Med
Pays: United States
ID NLM: 9418450

Informations de publication

Date de publication:
09 2020
Historique:
received: 22 05 2020
revised: 18 06 2020
accepted: 18 06 2020
pubmed: 1 8 2020
medline: 17 12 2020
entrez: 1 8 2020
Statut: ppublish

Résumé

There have been reports of procoagulant activity in patients with COVID-19. Whether there is an association between pulmonary embolism (PE) and COVID-19 in the emergency department (ED) is unknown. The aim of this study was to assess whether COVID-19 is associated with PE in ED patients who underwent a computed tomographic pulmonary angiogram (CTPA). A retrospective study in 26 EDs from six countries. ED patients in whom a CTPA was performed for suspected PE during a 2-month period covering the pandemic peak. The primary endpoint was the occurrence of a PE on CTPA. COVID-19 was diagnosed in the ED either on CT or reverse transcriptase-polymerase chain reaction. A multivariable binary logistic regression was built to adjust with other variables known to be associated with PE. A sensitivity analysis was performed in patients included during the pandemic period. A total of 3,358 patients were included, of whom 105 were excluded because COVID-19 status was unknown, leaving 3,253 for analysis. Among them, 974 (30%) were diagnosed with COVID-19. Mean (±SD) age was 61 (±19) years and 52% were women. A PE was diagnosed on CTPA in 500 patients (15%). The risk of PE was similar between COVID-19 patients and others (15% in both groups). In the multivariable binary logistic regression model, COVID-19 was not associated with higher risk of PE (adjusted odds ratio = 0.98, 95% confidence interval = 0.76 to 1.26). There was no association when limited to patients in the pandemic period. In ED patients who underwent CTPA for suspected PE, COVID-19 was not associated with an increased probability of PE diagnosis. These results were also valid when limited to the pandemic period. However, these results may not apply to patients with suspected COVID-19 in general.

Sections du résumé

BACKGROUND
There have been reports of procoagulant activity in patients with COVID-19. Whether there is an association between pulmonary embolism (PE) and COVID-19 in the emergency department (ED) is unknown. The aim of this study was to assess whether COVID-19 is associated with PE in ED patients who underwent a computed tomographic pulmonary angiogram (CTPA).
METHODS
A retrospective study in 26 EDs from six countries. ED patients in whom a CTPA was performed for suspected PE during a 2-month period covering the pandemic peak. The primary endpoint was the occurrence of a PE on CTPA. COVID-19 was diagnosed in the ED either on CT or reverse transcriptase-polymerase chain reaction. A multivariable binary logistic regression was built to adjust with other variables known to be associated with PE. A sensitivity analysis was performed in patients included during the pandemic period.
RESULTS
A total of 3,358 patients were included, of whom 105 were excluded because COVID-19 status was unknown, leaving 3,253 for analysis. Among them, 974 (30%) were diagnosed with COVID-19. Mean (±SD) age was 61 (±19) years and 52% were women. A PE was diagnosed on CTPA in 500 patients (15%). The risk of PE was similar between COVID-19 patients and others (15% in both groups). In the multivariable binary logistic regression model, COVID-19 was not associated with higher risk of PE (adjusted odds ratio = 0.98, 95% confidence interval = 0.76 to 1.26). There was no association when limited to patients in the pandemic period.
CONCLUSION
In ED patients who underwent CTPA for suspected PE, COVID-19 was not associated with an increased probability of PE diagnosis. These results were also valid when limited to the pandemic period. However, these results may not apply to patients with suspected COVID-19 in general.

Identifiants

pubmed: 32734624
doi: 10.1111/acem.14096
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

811-820

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 by the Society for Academic Emergency Medicine.

Références

Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20.
Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020; 382:e38.
Klok FA, Kruip MJ, van der Meer NJ, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020;191:145-7.
Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Int Med 2020;180:934.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62.
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18:1094-10.
Freund Y, Cachanado M, Aubry A, et al. Effect of the pulmonary embolism rule-out criteria on subsequent thromboembolic events among low-risk emergency department patients: the PROPER randomized clinical trial. JAMA 2018;319:559-66.
Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000;83:416-20.
Le Gal G, Righini M, Roy PM, et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med 2006;144:165-71.
van der Hulle T, Cheung WY, Kooij S, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet 2017;390:289-97.
Bernheim A, Mei X, Huang M, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology 2020;295:200463.
Jiang Y, Guo D, Li C, Chen T, Li R. High-resolution CT features of the COVID-19 infection in Nanchong City: initial and follow-up changes among different clinical types. Radiol Infect Dis 2020 [online ahead of print]. https://doi.org/10.1016/j.jrid.2020.05.001
Li K, Fang Y, Li W, et al. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol 2020;30:4407-16.
Simpson S, Kay FU, Abbara S, et al. Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imag 2020;2:e200152.
Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA 2014;311:1117-24.
Klok FA, Mos IC, Nijkeuter M, et al. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. Arch Intern Med 2008; 168:2131-6.
Poissy J, Goutay J, Caplan M, et al. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation 2020;142:184-6.
Grillet F, Behr J, Calame P, Aubry S, Delabrousse E. Acute pulmonary embolism associated with COVID-19 pneumonia detected by pulmonary CT angiography. Radiology 2020;201544.
Kline JA, Richardson DM, Than MP, Penaloza A, Roy PM. Systematic review and meta-analysis of pregnant patients investigated for suspected pulmonary embolism in the emergency department. Acad Emerg Med 2014;21:949-59.
Watson J, Whiting PF, Brush JE. Interpreting a covid-19 test result. BMJ 2020;369:m1808.
Adams HJ, Kwee TC, Yakar D, Hope MD, Kwee RM. Systematic review and meta-analysis on the value of chest CT in the diagnosis of coronavirus disease (COVID-19): sol scientiae, illustra nos. AJR Am J Roentgenol 2020;1-10.
Bai HX, Hsieh B, Xiong Z, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology 2020;200823.
Kim H, Hong H, Yoon SH. Diagnostic performance of CT and reverse transcriptase-polymerase chain reaction for coronavirus disease 2019: a meta-analysis. Radiology 2020;201343

Auteurs

Yonathan Freund (Y)

From, Sorbonne Université, Paris, France.
the, Emergency Department, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), APHP.SU, Paris, France.

Marie Drogrey (M)

the, Emergency Department, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), APHP.SU, Paris, France.

Òscar Miró (Ò)

the, Emergency Departement, Hospital Clínic, Barcelona, Catalonia, Spain.

Alessio Marra (A)

the, Emergency Department, Centro EAS-Emergenza Alta Specializzazione, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.

Anne-Laure Féral-Pierssens (AL)

the, Charles Lemoyne-Saguenay Lac Saint-Jean Research Center on Health Innovations (CR CSIS), Sherbrooke University, Longueuil, Québec, Canada.
the, Emergency Department, European Georges Pompidou hospital, APHP, Paris, France.

Andrea Penaloza (A)

the, Service des Urgences, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.

Barbara A Lara Hernandez (BAL)

the, Emergency Medicine Section, Pontificia Universidad Católica de Chile, Santiago, Chile.

Sebastien Beaune (S)

the, Emergency Department, Hôpital Ambroise-Paré, APHP, Boulogne, INSERM UMR 1144, Université Paris Centre, Paris, France.

Judith Gorlicki (J)

the, Emergency Department, SAMU 93, Avicenne University Hospital, APHP.HUPSSD, Bobigny, France.
INSERM UMR-S 942, Sorbonne Paris Nord University, Bobigny, France.

Prabakar Vaittinada Ayar (P)

the, Emergency Department, University Hospital of Beaujon, APHP, Clichy, France.
UMR-S 942, INSERM, MASCOT, Paris, France.
University, Paris, France.

Jennifer Truchot (J)

the, Emergency Department, Cochin Hospital, Hôpitaux Universitaire Paris Centre, APHP, Paris, France.

Barbara Pena (B)

the, Emergency Department, Hospital General Universitario de Alicante, Alicante, Spain.

Alfons Aguirre (A)

the, Emergency Department, Hospital del Mar, Barcelona, Catalonia, Spain.

Florent Fémy (F)

the, Emergency Department, Georges Pompidou European Hospital, APHP, Université de Paris, Paris, France.
the, Toxicology and Chemical Risks Department, French Armed Forces Biomedical Institute, Bretigny-Sur-Orges, France.

Nicolas Javaud (N)

the, Emergency Department, Louis Mourier Hospital, University of Paris, APHP.North, Paris, France.

Anthony Chauvin (A)

the, Emergency Department, Hopital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France.
the, Faculté de Médecine, Université de Paris, Paris, France.

Tahar Chouihed (T)

the, Emergency Department, Université de Lorraine, University Hospital of Nancy, Centre d'Investigations Cliniques-1433, and INSERM UMR_S 1116, Nancy, France.
the, F-CRIN INI-CRCT, Nancy, France.

Emmanuel Montassier (E)

the, Department of Emergency Medicine, CHU Nantes, Nantes, France.
the, MiHAR Laboratory, Université de Nantes, Nantes, France.

Pierre-Géraud Claret (PG)

the, Department of Anesthesia Resuscitation Pain Emergency Medicine, Nîmes University Hospital, Nîmes, France.

Céline Occelli (C)

the, Emergency Department, CHU Pasteur 2, Nice, France.
the, University Nice Côte d'Azur, Nice, France.

Mélanie Roussel (M)

the, Emergency Department, Rouen University Hospital, Rouen, France.

Fabien Brigant (F)

the, Emergency Department, Hôpital Saint-Antoine, APHP.SU, Paris, France.

Sami Ellouze (S)

the, Emergency Department, Hôpital Saint-Louis, APHP, Paris, France.

Pierrick Le Borgne (P)

the, Emergency Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
the, INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative NanoMedicine (RNM), Fédération de Médecine Translationnelle (FMTS), University of Strasbourg, Strasbourg, France.

Said Laribi (S)

the, Emergency Department, School of Medicine and CHU Tours, Tours University, Tours, France.

Tabassome Simon (T)

From, Sorbonne Université, Paris, France.
the, Clinical Research Platform (URC-CRC-CRB), AP-HP Hôpital Saint-Antoine, Paris, France.

Olivier Lucidarme (O)

From, Sorbonne Université, Paris, France.
the, APHP-Sorbonne Universités, Pitié Salpêtrière Hospital, Radiology Department and UPMC Univ Paris 06, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, Paris, France.

Marine Cachanado (M)

the, Emergency Department, Royal London Hospital, Barts Health NHS Trust, London, UK.

Ben Bloom (B)

and the, Emergency Department, European Georges Pompidou Hospital, APHP, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH